Zalsupindole

N/A

Report date: 2025/11/03 11:47:37
NME

Base Information

Drug NameZalsupindole
Drug Alias NameDLX-1DLX-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDepressive Disorder, MajorCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDelix Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesDelix Therapeutics
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, MajorCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A